BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15054519)

  • 1. Immunohistochemical assessment of angiogenesis in primary hepatocellular carcinoma.
    Săftoiu A; Ciurea T; Baniţă M; Georgescu C; Comănescu V; Rogoveanu I; Gorunescu F; Georgescu I
    Rom J Gastroenterol; 2004 Mar; 13(1):3-8. PubMed ID: 15054519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways.
    Zhao ZC; Zheng SS; Wan YL; Jia CK; Xie HY
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):529-36. PubMed ID: 14627514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular density and VEGF expression in hepatic lesions.
    Brodsky SV; Mendelev N; Melamed M; Ramaswamy G
    J Gastrointestin Liver Dis; 2007 Dec; 16(4):373-7. PubMed ID: 18193117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
    Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
    Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of the expression of VEGF and KDR on the angiogenesis, growth and metastasis of hepatocellular carcinoma].
    Zhao A; Dou K; Li K; Fu Y
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):453-6. PubMed ID: 11832083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S; Higashi T; Nouso K; Kariyama K; Nakamura S; Suzuki M; Nakatsukasa H; Kobayashi Y; Hanafusa T; Tsuji T; Shiratori Y
    J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression.
    Lee TK; Poon RT; Yuen AP; Man K; Yang ZF; Guan XY; Fan ST
    Clin Cancer Res; 2006 Sep; 12(17):5082-9. PubMed ID: 16951224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma.
    Poon RT; Chung KK; Cheung ST; Lau CP; Tong SW; Leung KL; Yu WC; Tuszynski GP; Fan ST
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4150-7. PubMed ID: 15217952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
    Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
    J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.
    Nakamura K; Zen Y; Sato Y; Kozaka K; Matsui O; Harada K; Nakanuma Y
    Hum Pathol; 2007 Oct; 38(10):1532-46. PubMed ID: 17640715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma.
    Yamaguchi R; Yano H; Nakashima O; Akiba J; Nishida N; Kurogi M; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):152-60. PubMed ID: 16706827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Wang B; Xu H; Gao ZQ; Ning HF; Sun YQ; Cao GW
    Acta Radiol; 2008 Jun; 49(5):523-9. PubMed ID: 18568538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma].
    Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ
    Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha.
    Wada H; Nagano H; Yamamoto H; Yang Y; Kondo M; Ota H; Nakamura M; Yoshioka S; Kato H; Damdinsuren B; Tang D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Sakon M; Dono K; Wakasa K; Monden M
    Liver Int; 2006 May; 26(4):414-23. PubMed ID: 16629644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of hepatocellular carcinoma evaluated by vascular endothelial growth factor expression.
    Amaoka N; Osada S; Kanematsu M; Imai H; Tomita H; Tokuyama Y; Sakashita F; Nonaka K; Goshima S; Kondo H; Adachi Y
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2202-7. PubMed ID: 18031381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.